Metabolism and synthesis of arginine vasopressin in conscious newborn sheep

Darryl C. Miao, Sithembiso C. Velaphi, Timothy Roy, Kevin DeSpain, Charles R. Rosenfeld

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Arginine vasopressin (AVP) is an important regulator of cardiovascular homeostasis in the fetus, but its role after birth is unclear. Although infused AVP increases mean arterial pressure (MAP) during the 1st mo after birth, pressor responses are unchanged, suggesting that vascular responsiveness is also unchanged. Alternatively, this could reflect increases in AVP metabolic clearance rate (MCRAVP). However, newborn AVP metabolism and synthesis are poorly studied. Therefore, we examined the pressor responses to infused AVP and the pattern of circulating AVP, AVP production rate (PR AVP), and MCRAVP in conscious newborn sheep (n = 5) at 9-38 days after birth. Basal MAP rose and heart rate (HR) fell during the study period (P ≤ 0.02), while circulating AVP was unchanged (P > 0.1), averaging 3.01 ± 0.86 pg/ml. Infused AVP elicited steady-state responses at 10-40 min, increasing plasma AVP and MAP and decreasing HR (P < 0.001). Although pressor responses were unchanged between 9 and 38 days, the rise in MAP correlated with increases in plasma AVP (R = 0.47, P = 0.02, n = 24). MCR AVP was unchanged throughout the 1st mo (P < 0.2), averaging 205 ± 17 ml·kg-1·min-1, and was associated with an elevated PRAVP, 973 ± 267 pg·kg -1·min-1, which also was unchanged (P < 0.1). After birth, MCRAVP and PRAVP are elevated, probably accounting for the stable plasma AVP levels. The former is also likely to account for the stable pressor responses to infused AVP during the 1st mo. The reason for the elevated PRAVP is unclear but may relate to increases in vascular volume associated with postnatal growth.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Endocrinology and Metabolism
Volume295
Issue number3
DOIs
StatePublished - Sep 2008

Fingerprint

Arginine Vasopressin
Sheep
Arterial Pressure
Parturition
Blood Vessels
Heart Rate
Metabolic Clearance Rate

Keywords

  • Arginine vasopressin production rate
  • Metabolic clearance rate
  • Neonatal blood pressure

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)
  • Endocrinology, Diabetes and Metabolism

Cite this

Metabolism and synthesis of arginine vasopressin in conscious newborn sheep. / Miao, Darryl C.; Velaphi, Sithembiso C.; Roy, Timothy; DeSpain, Kevin; Rosenfeld, Charles R.

In: American Journal of Physiology - Endocrinology and Metabolism, Vol. 295, No. 3, 09.2008.

Research output: Contribution to journalArticle

@article{59e9b8da4dae4abfafe16beceb942df6,
title = "Metabolism and synthesis of arginine vasopressin in conscious newborn sheep",
abstract = "Arginine vasopressin (AVP) is an important regulator of cardiovascular homeostasis in the fetus, but its role after birth is unclear. Although infused AVP increases mean arterial pressure (MAP) during the 1st mo after birth, pressor responses are unchanged, suggesting that vascular responsiveness is also unchanged. Alternatively, this could reflect increases in AVP metabolic clearance rate (MCRAVP). However, newborn AVP metabolism and synthesis are poorly studied. Therefore, we examined the pressor responses to infused AVP and the pattern of circulating AVP, AVP production rate (PR AVP), and MCRAVP in conscious newborn sheep (n = 5) at 9-38 days after birth. Basal MAP rose and heart rate (HR) fell during the study period (P ≤ 0.02), while circulating AVP was unchanged (P > 0.1), averaging 3.01 ± 0.86 pg/ml. Infused AVP elicited steady-state responses at 10-40 min, increasing plasma AVP and MAP and decreasing HR (P < 0.001). Although pressor responses were unchanged between 9 and 38 days, the rise in MAP correlated with increases in plasma AVP (R = 0.47, P = 0.02, n = 24). MCR AVP was unchanged throughout the 1st mo (P < 0.2), averaging 205 ± 17 ml·kg-1·min-1, and was associated with an elevated PRAVP, 973 ± 267 pg·kg -1·min-1, which also was unchanged (P < 0.1). After birth, MCRAVP and PRAVP are elevated, probably accounting for the stable plasma AVP levels. The former is also likely to account for the stable pressor responses to infused AVP during the 1st mo. The reason for the elevated PRAVP is unclear but may relate to increases in vascular volume associated with postnatal growth.",
keywords = "Arginine vasopressin production rate, Metabolic clearance rate, Neonatal blood pressure",
author = "Miao, {Darryl C.} and Velaphi, {Sithembiso C.} and Timothy Roy and Kevin DeSpain and Rosenfeld, {Charles R.}",
year = "2008",
month = "9",
doi = "10.1152/ajpendo.90441.2008",
language = "English (US)",
volume = "295",
journal = "American Journal of Physiology - Heart and Circulatory Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "3",

}

TY - JOUR

T1 - Metabolism and synthesis of arginine vasopressin in conscious newborn sheep

AU - Miao, Darryl C.

AU - Velaphi, Sithembiso C.

AU - Roy, Timothy

AU - DeSpain, Kevin

AU - Rosenfeld, Charles R.

PY - 2008/9

Y1 - 2008/9

N2 - Arginine vasopressin (AVP) is an important regulator of cardiovascular homeostasis in the fetus, but its role after birth is unclear. Although infused AVP increases mean arterial pressure (MAP) during the 1st mo after birth, pressor responses are unchanged, suggesting that vascular responsiveness is also unchanged. Alternatively, this could reflect increases in AVP metabolic clearance rate (MCRAVP). However, newborn AVP metabolism and synthesis are poorly studied. Therefore, we examined the pressor responses to infused AVP and the pattern of circulating AVP, AVP production rate (PR AVP), and MCRAVP in conscious newborn sheep (n = 5) at 9-38 days after birth. Basal MAP rose and heart rate (HR) fell during the study period (P ≤ 0.02), while circulating AVP was unchanged (P > 0.1), averaging 3.01 ± 0.86 pg/ml. Infused AVP elicited steady-state responses at 10-40 min, increasing plasma AVP and MAP and decreasing HR (P < 0.001). Although pressor responses were unchanged between 9 and 38 days, the rise in MAP correlated with increases in plasma AVP (R = 0.47, P = 0.02, n = 24). MCR AVP was unchanged throughout the 1st mo (P < 0.2), averaging 205 ± 17 ml·kg-1·min-1, and was associated with an elevated PRAVP, 973 ± 267 pg·kg -1·min-1, which also was unchanged (P < 0.1). After birth, MCRAVP and PRAVP are elevated, probably accounting for the stable plasma AVP levels. The former is also likely to account for the stable pressor responses to infused AVP during the 1st mo. The reason for the elevated PRAVP is unclear but may relate to increases in vascular volume associated with postnatal growth.

AB - Arginine vasopressin (AVP) is an important regulator of cardiovascular homeostasis in the fetus, but its role after birth is unclear. Although infused AVP increases mean arterial pressure (MAP) during the 1st mo after birth, pressor responses are unchanged, suggesting that vascular responsiveness is also unchanged. Alternatively, this could reflect increases in AVP metabolic clearance rate (MCRAVP). However, newborn AVP metabolism and synthesis are poorly studied. Therefore, we examined the pressor responses to infused AVP and the pattern of circulating AVP, AVP production rate (PR AVP), and MCRAVP in conscious newborn sheep (n = 5) at 9-38 days after birth. Basal MAP rose and heart rate (HR) fell during the study period (P ≤ 0.02), while circulating AVP was unchanged (P > 0.1), averaging 3.01 ± 0.86 pg/ml. Infused AVP elicited steady-state responses at 10-40 min, increasing plasma AVP and MAP and decreasing HR (P < 0.001). Although pressor responses were unchanged between 9 and 38 days, the rise in MAP correlated with increases in plasma AVP (R = 0.47, P = 0.02, n = 24). MCR AVP was unchanged throughout the 1st mo (P < 0.2), averaging 205 ± 17 ml·kg-1·min-1, and was associated with an elevated PRAVP, 973 ± 267 pg·kg -1·min-1, which also was unchanged (P < 0.1). After birth, MCRAVP and PRAVP are elevated, probably accounting for the stable plasma AVP levels. The former is also likely to account for the stable pressor responses to infused AVP during the 1st mo. The reason for the elevated PRAVP is unclear but may relate to increases in vascular volume associated with postnatal growth.

KW - Arginine vasopressin production rate

KW - Metabolic clearance rate

KW - Neonatal blood pressure

UR - http://www.scopus.com/inward/record.url?scp=53149126105&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=53149126105&partnerID=8YFLogxK

U2 - 10.1152/ajpendo.90441.2008

DO - 10.1152/ajpendo.90441.2008

M3 - Article

C2 - 18612043

AN - SCOPUS:53149126105

VL - 295

JO - American Journal of Physiology - Heart and Circulatory Physiology

JF - American Journal of Physiology - Heart and Circulatory Physiology

SN - 0363-6135

IS - 3

ER -